Etoposide

drugbox
IUPAC_name = 4'-demethyl-epipodophyllotoxin 9- [4,6-O-("R")-ethylidene-beta-D-glucopyranoside] , 4' -(dihydrogen phosphate)

---

CAS_number = 33419-42-0
ATC_prefix = L01
ATC_suffix = CB01
ATC_supplemental =
PubChem = 36462
DrugBank = APRD00239
C = 29 | H = 32 | O = 13
molecular_weight = 588.557 g/mol
bioavailability = Highly variable, 25 to 75%
protein_bound = 97%
metabolism = Hepatic (CYP3A4 involved)
elimination_half-life = Oral: 6 h., IV: 6-12 h., IV in children: 3 h.
pregnancy_AU = D
pregnancy_US = D
legal_UK = POM
legal_US = Rx-only
routes_of_administration = Oral, intravenous
excretion = Renal and fecal

Etoposide phosphate (brand names: Eposin, Etopophos, Vepesid, VP-16) is an inhibitor of the enzyme topoisomerase II. It is used as a form of chemotherapy for malignancies such as Ewing's sarcoma, lung cancer, testicular cancer, lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme. It is often given in combination with other drugs. It is also sometimes used in a conditioning regimen prior to a bone marrow or blood stem cell transplant.

Chemically it derives from podophyllotoxin, a toxin found in the American Mayapple.

Administration

It is given intravenously or orally in capsule form. If the drug is given by IV it must be done slowly over a 30 to 60 minute period because it can lower blood pressure as it is being administered. Blood pressure is checked often during infusing with the speed of administration adjusted accordingly.

Patients are generally advised to call their doctor in case of fever, symptoms of infection or painful injection sites, as these may progress severely without adequate medical attention.

Patients are advised to drink large amounts of fluids after treatment to prevent damage to the bladder and kidneys, typically 1.5 to 3.5 litres of water on the day of treatment and for several days after.

ide effects

Common are:
* low blood pressure
* hair loss
* pain and or burning at the IV site
* constipation or diarrhea
* metallic food taste
* Bone marrow suppression, leading to:
** decreased white blood cell counts (leading to increased susceptibility to infections)
** low red blood cell counts (anemia)
** low platelet counts (leading to easy bruising and bleeding)

Less common are:
* nausea and vomiting
* allergic type reactions
* rash
* fever, often occurring shortly after IV administration and not due to infection
* mouth sores
* Acute myeloid leukemia

External links

* [http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailT.aspx?int_id=81 Etoposide information at the U.S. National Institutes of Health]